Selected article for: "IFN response and STAT1 phosphorylation"

Author: Kumari G. Lokugamage; Adam Hage; Craig Schindewolf; Ricardo Rajsbaum; Vineet D. Menachery
Title: SARS-CoV-2 is sensitive to type I interferon pretreatment
  • Document date: 2020_3_9
  • ID: 2w0zr9c0_13
    Snippet: CoV. Using Vero E6 cells, we demonstrate that SARS-CoV-2 maintains similar viral replication 66 kinetics as SARS-CoV following a low dose infection. In contrast, we find that SARS-CoV-2 is 67 much more sensitive to IFN-I pretreatment as compared to SARS-CoV. Examining further, we 68 determined that SARS-CoV-2 induces STAT1 phosphorylation and ISG expression, which is 69 absent in SARS-CoV. Similarly, infection of IFN competent Calu3 2B4 cells res.....
    Document: CoV. Using Vero E6 cells, we demonstrate that SARS-CoV-2 maintains similar viral replication 66 kinetics as SARS-CoV following a low dose infection. In contrast, we find that SARS-CoV-2 is 67 much more sensitive to IFN-I pretreatment as compared to SARS-CoV. Examining further, we 68 determined that SARS-CoV-2 induces STAT1 phosphorylation and ISG expression, which is 69 absent in SARS-CoV. Similarly, infection of IFN competent Calu3 2B4 cells resulted in reduced 70 SARS-Cov-2 replication and STAT1 phosphorylation at late times. These results suggest 71 distinct changes between the CoVs in terms of IFN antagonism and we subsequently examined 72 sequence homology between the SARS-CoV and SARS-CoV-2 viral proteins that may be 73 responsible for these differences. Together, the results suggest SARS-CoV-2 lacks the same 74 capacity to control the IFN-I response as SARS-CoV. 75

    Search related documents:
    Co phrase search for related documents
    • dose infection and IFN response: 1, 2, 3, 4, 5, 6
    • dose infection and low dose infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • dose infection and SARS compare: 1, 2
    • dose infection and SARS induce: 1, 2, 3
    • dose infection and SARS viral protein: 1
    • dose infection and viral protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • IFN antagonism and SARS viral protein: 1
    • IFN antagonism and viral protein: 1, 2, 3
    • IFN response and ISG phosphorylation: 1, 2, 3, 4, 5, 6
    • IFN response and ISG phosphorylation expression: 1, 2
    • IFN response and late time: 1
    • IFN response and SARS induce: 1, 2, 3, 4, 5, 6
    • IFN response and SARS viral protein: 1
    • IFN response and similar viral replication: 1, 2, 3
    • IFN response and stat1 replication: 1, 2, 3, 4, 5
    • IFN response and stat1 replication phosphorylation: 1
    • ISG phosphorylation and similar viral replication: 1, 2
    • ISG phosphorylation and stat1 replication: 1
    • ISG phosphorylation and stat1 replication phosphorylation: 1